NYSE:MCK (USA) Also trade in: Germany Mexico UK

McKesson Corp

$ 133.17 -0.66 (-0.49%)
Volume: 731,931 Avg Vol (1m): 1,411,481
Market Cap $: 25.38 Bil Enterprise Value $: 30.19 Bil
P/E (TTM): 2,226.66 P/B: 3.15
Earnings Power Value -9.58
Net Current Asset Value -68.65
Tangible Book -25.93
Projected FCF 241.97
Median P/S Value 185.28
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.39
Cash-To-Debt ranked lower than
67.80% of 59 companies
in the Medical Distribution industry.
Industry Max: 10000, Med: 0.69, Min: 0.02
MCK: 0.39
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.1, Med: 0.48, Max: 2.16
Current: 0.39
0.1
2.16
Equity-to-Asset 0.14
Equity-to-Asset ranked lower than
93.10% of 58 companies
in the Medical Distribution industry.
Industry Max: 0.98, Med: 0.44, Min: 0.08
MCK: 0.14
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.14, Med: 0.26, Max: 0.35
Current: 0.14
0.14
0.35
Debt-to-Equity 0.94
Debt-to-Equity ranked lower than
63.27% of 49 companies
in the Medical Distribution industry.
Industry Max: 2.29, Med: 0.56, Min: 0.01
MCK: 0.94
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0.17, Med: 0.56, Max: 1.24
Current: 0.94
0.17
1.24
Debt-to-EBITDA 4.17
Debt-to-EBITDA ranked higher than
65.91% of 44 companies
in the Medical Distribution industry.
Industry Max: 22.5, Med: 2.37, Min: 0.07
MCK: 4.17
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 1.04, Med: 1.78, Max: 5.35
Current: 4.17
1.04
5.35
Interest Coverage 12.06
Interest Coverage ranked higher than
58.82% of 51 companies
in the Medical Distribution industry.
Industry Max: 61491.55, Med: 12.71, Min: 0.12
MCK: 12.06
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 8.34, Med: 10.03, Max: 12.42
Current: 12.06
8.34
12.42
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.24
DISTRESS
GREY
SAFE
WACC vs ROIC %
ROIC 8.37%
WACC 8.29%

Profitability & Growth : 7/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 1.49
Operating Margin ranked lower than
54.24% of 59 companies
in the Medical Distribution industry.
Industry Max: 66.85, Med: 3.6, Min: -286.7
MCK: 1.49
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 1.4, Med: 1.82, Max: 1.91
Current: 1.49
1.4
1.91
Net Margin % 0.02
Net Margin ranked lower than
50.85% of 59 companies
in the Medical Distribution industry.
Industry Max: 38.05, Med: 2.61, Min: -158.62
MCK: 0.02
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: 0.02, Med: 1.08, Max: 2.55
Current: 0.02
0.02
2.55
ROE % 0.37
ROE ranked higher than
98.31% of 59 companies
in the Medical Distribution industry.
Industry Max: 45.32, Med: 9.39, Min: -305.4
MCK: 0.37
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: 0.37, Med: 18.14, Max: 50.65
Current: 0.37
0.37
50.65
ROA % 0.06
ROA ranked higher than
88.14% of 59 companies
in the Medical Distribution industry.
Industry Max: 22.61, Med: 3.37, Min: -57.72
MCK: 0.06
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: 0.06, Med: 4.01, Max: 8.63
Current: 0.06
0.06
8.63
ROC (Joel Greenblatt) % 29.91
ROC (Joel Greenblatt) ranked higher than
96.55% of 58 companies
in the Medical Distribution industry.
Industry Max: 597.86, Med: 22.92, Min: -4077.83
MCK: 29.91
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 21.95, Med: 175.99, Max: 315.05
Current: 29.91
21.95
315.05
3-Year Total Revenue Growth Rate 3.90
3-Year Revenue Growth Rate ranked higher than
68.09% of 47 companies
in the Medical Distribution industry.
Industry Max: 136.3, Med: 9.7, Min: -59.7
MCK: 9.9
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -13.6, Med: 10.65, Max: 23.7
Current: 9.9
-13.6
23.7
3-Year Total EBITDA Growth Rate -25.90
3-Year EBITDA Growth Rate ranked higher than
92.68% of 41 companies
in the Medical Distribution industry.
Industry Max: 50.9, Med: 8.6, Min: -183.4
MCK: -21.7
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: -68.1, Med: 14.2, Max: 297.2
Current: -21.7
-68.1
297.2
3-Year EPS w/o NRI Growth Rate -74.10
3-Year EPS w/o NRI Growth Rate ranked higher than
97.50% of 40 companies
in the Medical Distribution industry.
Industry Max: 56.4, Med: 6.1, Min: -192.4
MCK: -74.1
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
N/A

» MCK's 30-Y Financials

Financials (Next Earnings Date: 2019-07-26)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:MCK

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Distribution » Medical Distribution    NAICS : 424210    SIC : 5122
Compare NYSE:ABC NYSE:CAH HKSE:01099 NAS:HSIC SHSE:601607 XKRX:091990 HAM:CLS1 TSE:7459 SHSE:600763 SZSE:200028 NZSE:EBO LSE:UDG SHSE:600056 NAS:PDCO LSE:CLIN TSE:7476 SZSE:002589 NYSE:PBH SHSE:603368 SHSE:600090
Traded in other countries 0JZU.UK
Address One Post Street, San Francisco, CA, USA, 94104
McKesson is one of three major distributors of pharmaceuticals in the U.S. The firm also has significant specialty drug and medical product wholesaling operations. The firm plays a critical role along the pharmaceutical supply chain as it is able to procure and distribute drugs more efficiently than its pharmacy client and pharma manufacturing suppliers.

Ratios

Current vs industry vs history
PE Ratio (TTM) 2226.66
PE Ratio ranked higher than
93.75% of 48 companies
in the Medical Distribution industry.
Industry Max: 87.45, Med: 19, Min: 5.01
MCK: 2226.66
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 5.83, Med: 17.43, Max: 2252.33
Current: 2226.66
5.83
2252.33
Forward PE Ratio 9.48
Forward P/E ranked higher than
76.92% of 13 companies
in the Medical Distribution industry.
Industry Max: 27.32, Med: 13.99, Min: 8.58
MCK: 9.48
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 2226.66
PE without NRI ranked higher than
93.75% of 48 companies
in the Medical Distribution industry.
Industry Max: 87.45, Med: 19.94, Min: 5.01
MCK: 2226.66
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 5.69, Med: 17.35, Max: 2252.33
Current: 2226.66
5.69
2252.33
Price-to-Owner-Earnings 20.15
Price-to-Owner-Earnings ranked higher than
94.29% of 35 companies
in the Medical Distribution industry.
Industry Max: 1924, Med: 18.94, Min: 0.83
MCK: 20.15
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 3.77, Med: 12.5, Max: 76.5
Current: 20.15
3.77
76.5
PB Ratio 3.15
PB Ratio ranked lower than
60.34% of 58 companies
in the Medical Distribution industry.
Industry Max: 95.24, Med: 2.12, Min: 0.17
MCK: 3.15
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 1.31, Med: 2.96, Max: 6.98
Current: 3.15
1.31
6.98
PS Ratio 0.12
PS Ratio ranked higher than
87.93% of 58 companies
in the Medical Distribution industry.
Industry Max: 37.5, Med: 0.91, Min: 0.04
MCK: 0.12
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.08, Med: 0.17, Max: 0.32
Current: 0.12
0.08
0.32
Price-to-Free-Cash-Flow 7.29
Price-to-Free-Cash-Flow ranked lower than
52.00% of 25 companies
in the Medical Distribution industry.
Industry Max: 243.06, Med: 14.2, Min: 2.16
MCK: 7.29
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 5.4, Med: 11.86, Max: 41.89
Current: 7.29
5.4
41.89
Price-to-Operating-Cash-Flow 6.31
Price-to-Operating-Cash-Flow ranked higher than
51.61% of 31 companies
in the Medical Distribution industry.
Industry Max: 237.48, Med: 12.02, Min: 1.81
MCK: 6.31
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 4.87, Med: 9.92, Max: 89.13
Current: 6.31
4.87
89.13
EV-to-EBIT 34.53
EV-to-EBIT ranked higher than
93.75% of 48 companies
in the Medical Distribution industry.
Industry Max: 271.97, Med: 14.52, Min: 0.25
MCK: 34.53
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: 4.9, Med: 11.6, Max: 604.7
Current: 34.53
4.9
604.7
EV-to-EBITDA 16.55
EV-to-EBITDA ranked higher than
95.83% of 48 companies
in the Medical Distribution industry.
Industry Max: 210.86, Med: 11.88, Min: 0.25
MCK: 16.55
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 4.3, Med: 9.2, Max: 37.3
Current: 16.55
4.3
37.3
EV-to-Revenue 0.14
EV-to-Revenue ranked higher than
93.10% of 58 companies
in the Medical Distribution industry.
Industry Max: 34.16, Med: 0.93, Min: 0.1
MCK: 0.14
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.1, Med: 0.2, Max: 0.4
Current: 0.14
0.1
0.4
Shiller PE Ratio 18.75
Shiller PE Ratio ranked higher than
66.67% of 21 companies
in the Medical Distribution industry.
Industry Max: 139.04, Med: 27.63, Min: 3.21
MCK: 18.75
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 14.43, Med: 27.13, Max: 51.86
Current: 18.75
14.43
51.86
Current Ratio 1.02
Current Ratio ranked lower than
90.74% of 54 companies
in the Medical Distribution industry.
Industry Max: 4.34, Med: 1.5, Min: 0.5
MCK: 1.02
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1.01, Med: 1.26, Max: 1.71
Current: 1.02
1.01
1.71
Quick Ratio 0.58
Quick Ratio ranked lower than
90.74% of 54 companies
in the Medical Distribution industry.
Industry Max: 3.95, Med: 1.12, Min: 0.23
MCK: 0.58
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.57, Med: 0.66, Max: 0.88
Current: 0.58
0.57
0.88
Days Inventory 29.91
Days Inventory ranked higher than
67.27% of 55 companies
in the Medical Distribution industry.
Industry Max: 720, Med: 41.27, Min: 0.96
MCK: 29.91
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 29.24, Med: 30.26, Max: 32.98
Current: 29.91
29.24
32.98
Days Sales Outstanding 25.45
Days Sales Outstanding ranked higher than
81.63% of 49 companies
in the Medical Distribution industry.
Industry Max: 411.94, Med: 60.84, Min: 2.1
MCK: 25.45
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 24.36, Med: 25.97, Max: 32.33
Current: 25.45
24.36
32.33
Days Payable 61.00
Days Payable ranked lower than
52.17% of 46 companies
in the Medical Distribution industry.
Industry Max: 616.64, Med: 62.55, Min: 1.62
MCK: 61
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 50.74, Med: 58.85, Max: 61
Current: 61
50.74
61

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 1.16
Trailing Dividend Yield ranked lower than
75.00% of 68 companies
in the Medical Distribution industry.
Industry Max: 15.22, Med: 1.59, Min: 0.15
MCK: 1.16
Ranked among companies with meaningful Trailing Dividend Yield only.
Trailing Dividend Yield range over the past 10 years
Min: 0.4, Med: 0.79, Max: 1.42
Current: 1.16
0.4
1.42
Dividend Payout Ratio 8.88
Dividend Payout Ratio ranked higher than
95.56% of 45 companies
in the Medical Distribution industry.
Industry Max: 1.46, Med: 0.28, Min: 0.03
MCK: 8.88
Ranked among companies with meaningful Dividend Payout Ratio only.
Dividend Payout Ratio range over the past 10 years
Min: 0.05, Med: 0.14, Max: 8.88
Current: 8.88
0.05
8.88
3-Year Dividend Growth Rate (Per Share) 11.80
3-Year Dividend Growth Rate ranked lower than
64.29% of 28 companies
in the Medical Distribution industry.
Industry Max: 53.7, Med: 12.7, Min: -100
MCK: 11.8
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
3-Year Dividend Growth Rate range over the past 10 years
Min: -21.7, Med: 3.15, Max: 44.2
Current: 11.8
-21.7
44.2
Forward Dividend Yield % 1.17
Forward Dividend Yield ranked lower than
76.81% of 69 companies
in the Medical Distribution industry.
Industry Max: 15.22, Med: 1.45, Min: 0.15
MCK: 1.17
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield-on-Cost (5-Year) % 1.91
Yield-on-Cost (5y) ranked lower than
83.10% of 71 companies
in the Medical Distribution industry.
Industry Max: 47.65, Med: 3.97, Min: 0.17
MCK: 1.91
Ranked among companies with meaningful Yield-on-Cost (5y) only.
Yield-on-Cost (5y) range over the past 10 years
Min: 0.65, Med: 1.29, Max: 2.32
Current: 1.91
0.65
2.32
3-Year Share Buyback Rate 4.30
3-Year Share Buyback Rate ranked higher than
95.12% of 41 companies
in the Medical Distribution industry.
Industry Max: 16.6, Med: -1.9, Min: -241.2
MCK: 4.3
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -46.3, Med: 0.35, Max: 5.7
Current: 4.3
-46.3
5.7

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 0.55
Price-to-Intrinsic-Value-Projected-FCF ranked higher than
92.31% of 26 companies
in the Medical Distribution industry.
Industry Max: 22.08, Med: 1.53, Min: 0.59
MCK: 0.55
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.48, Med: 0.93, Max: 9.29
Current: 0.55
0.48
9.29
Price-to-Median-PS-Value 0.72
Price-to-Median-PS-Value ranked higher than
60.47% of 43 companies
in the Medical Distribution industry.
Industry Max: 28.57, Med: 0.96, Min: 0.01
MCK: 0.72
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.54, Med: 1.08, Max: 1.76
Current: 0.72
0.54
1.76
Earnings Yield (Joel Greenblatt) % 2.90
Earnings Yield (Greenblatt) ranked higher than
94.92% of 59 companies
in the Medical Distribution industry.
Industry Max: 400, Med: 6.16, Min: -133.33
MCK: 2.9
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: 0.2, Med: 8.6, Max: 20.6
Current: 2.9
0.2
20.6
Forward Rate of Return (Yacktman) % 2.06
Forward Rate of Return ranked higher than
97.06% of 34 companies
in the Medical Distribution industry.
Industry Max: 28.1, Med: 12.37, Min: -43.08
MCK: 2.06
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: -23.5, Med: 21.8, Max: 30
Current: 2.06
-23.5
30

More Statistics

Revenue (TTM) (Mil) $ 214,319
EPS (TTM) $ 0.06
Beta 1.31
Volatility % 25.01
52-Week Range $ 106.11 - 149.43
Shares Outstanding (Mil) 189.96

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy Y
Less Shares Outstanding yoy Y
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y